Medicine
Prucalopride 2 mg tablet
Prucalopride 2 mg tablet is a generic prescription medicine for oral use, made by 17 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store Prucalopride tablets at 20°C to 25°C (68°F to 77°F), excursions…
Key facts
- Active ingredient (INN)
- Prucalopride
- Brand
- Sold under the generic name
- Strength
- 2 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 1 bottle and 15 more
- Manufacturers
- Alembic PharmaceuticalsIndiaAjanta PharmaIndiaCamber PharmaceuticalsIndiaCiplaIndiaLupinIndiaNovadoz PharmaceuticalsIndiaViona PharmaceuticalsIndiaZydus LifesciencesIndiaAmneal Pharmaceuticals NYANI Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store Prucalopride tablets at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Store prucalopride tablet in the original container to protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A06AX05 Prucalopride
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 December 2024
- Identifiers
- RxCUI 2107345, 2107353DailyMed set ID 124e8e82-972d-4800-9d68-14db416959b5, 6d82dfbd-f171-4045-9f7a-268e189a658a, 4a519883-9231-4ed3-966a-8d9fdbf4a3ac +15NDC 70748-390, 70954-597, 31722-392 +15Application ANDA218847, ANDA218492, ANDA219160 +11
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 46708-078-30 | Alembic PharmaceuticalsIndia | 31 July 2026 |
| 30 tablet, film coated in 1 bottle | 62332-078-30 | Alembic PharmaceuticalsIndia | 31 July 2026 |
| 30 tablet in 1 bottle | 27241-295-30 | Ajanta PharmaIndia | 16 January 2026 |
| 30 tablet, film coated in 1 bottle | 31722-392-30 | Camber PharmaceuticalsIndia | 24 June 2025 |
| 30 tablet, film coated in 1 bottle | 69097-219-02 | CiplaIndia | 25 June 2025 |
| 30 tablet, film coated in 1 bottle | 70748-390-01 | LupinIndia | 25 June 2025 |
| 30 tablet, film coated in 1 bottle | 72205-219-30 | Novadoz PharmaceuticalsIndia | 24 June 2025 |
| 30 tablet, film coated in 1 bottle | 72578-222-06 | Viona PharmaceuticalsIndia | 2 February 2026 |
| 30 tablet, film coated in 1 bottle | 70771-1900-3 | Zydus LifesciencesIndia | 2 February 2026 |
| 30 tablet, film coated in 1 bottle | 69238-2699-1 | Amneal Pharmaceuticals NY | 26 June 2025 |
| 30 tablet in 1 bottle | 70954-597-10 | ANI Pharmaceuticals | 27 December 2024 |
| 30 tablet, film coated in 1 bottle | 60505-4807-3 | Apotex | 24 June 2025 |
| 30 tablet, film coated in 1 bottle | 0054-0750-13 | Hikma Pharmaceuticals | 24 June 2025 |
| 30 tablet, film coated in 1 bottle | 0781-8159-31 | Sandoz | 13 June 2025 |
| 30 tablet, film coated in 1 bottle | 83085-006-30 | SKG Pharma | 24 June 2025 |
| 1 bottle in 1 bottle / 30 tablet in 1 bottle | 70069-822-01 | Somerset Therapeutics | 24 June 2025 |
| 30 tablet, film coated in 1 bottle | 0406-6302-03 | SpecGx | 24 June 2025 |
| 30 tablet, film coated in 1 bottle | 73190-039-30 | AvKARE | 25 July 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Prucalopride 2 mg tablet.
Other strengths and forms of Prucalopride
Clinical summary
Prucalopride is a serotonin-4 receptor agonist indicated for the treatment of chronic idiopathic constipation (CIC) in adults. It is available as tablets for oral use. MedsAcross supplies Prucalopride for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PrucaloprideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- MOTEGRITY prescribing information (Takeda Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Resolor: European public assessment report (EPAR) · European Medicines Agency
Need Prucalopride 2 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.